Combination Chemotherapy With or Without Anlotinib in the Maintenance Treatment of Non-Squamous Non-Small Cell Lung Cancer.

NCT04453423 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Non-squamous Non-small-cell Lung Cancer

Interventions

DRUG: Anlotinib + Pemetrexed+Carboplatin
DRUG: Pemetrexed
DRUG: Anlotinib + Pemetrexed
DRUG: Anlotinib

Sponsor

The First Affiliated Hospital with Nanjing Medical University